Convention on Biological Diversity (CBD) Nutraceuticals Market
By Product;
CBD Tinctures, Capsules & Soft Gels, CBD-Based Protein, CBD Gummies and OthersBy Application;
Wellness, Workout Supplements, Edibles & Fortified Foods and OthersBy Distribution Channel;
Retail Stores, Pharmacies, E-Commerce Portals and OthersBy Geography;
North America, Europe, Asia Pacific, Middle East & Africa and Latin America - Report Timeline (2021 - 2031)CBD Nutraceuticals Market Overview
CBD Nutraceuticals Market (USD Million)
CBD Nutraceuticals Market was valued at USD 9,988.70 million in the year 2024. The size of this market is expected to increase to USD 32,389.36 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 18.3%.
Convention on Biological Diversity (CBD) Nutraceuticals Market
*Market size in USD million
CAGR 18.3 %
| Study Period | 2025 - 2031 | 
|---|---|
| Base Year | 2024 | 
| CAGR (%) | 18.3 % | 
| Market Size (2024) | USD 9,988.70 Million | 
| Market Size (2031) | USD 32,389.36 Million | 
| Market Concentration | Low | 
| Report Pages | 342 | 
Major Players
- Medical Marijuana Inc.
- Isodiol
- Elixinol
- Diamond CBD
- Irwin Naturals
- MGC Pharma
- Aphria Inc.
- Charlotte's Web
- CV Sciences, Inc
Market Concentration
Consolidated - Market dominated by 1 - 5 major players
Convention on Biological Diversity (CBD) Nutraceuticals Market
Fragmented - Highly competitive market without dominant players
The CBD Nutraceuticals Market is flourishing thanks to technological advancements, as over 60% of innovation emphasizes nanoemulsified and liposome-based delivery systems. These configurations boost efficacy, ensuring better nutrient uptake. Reliable absorption is fueling steady growth and increasing user trust.
User-Friendly Formats Driving Market Uptake
Over 55% of development focuses on innovation in easy-to-use formats—like gummies, effervescent sticks, and drink additives. These designs enhance convenience, dosage accuracy, and sensory appeal. Delivery-focused innovation supports the market’s future outlook and promotes continuous growth in widespread use.
Business Consolidation Increasing Scale & Reach
Close to 35% of market advancement is driven by merger activities that unite extract houses with formulation labs and distribution partners. These integrations boost technological capabilities, expand production scale, and improve supply chain efficiency. The cohesive framework drives broad expansion of trusted nutraceutical brands.
AI-Driven Quality Checks Reinforcing Brand Confidence
With over 50% of companies incorporating AI analytics and traceability platforms, product consistency and safety are more transparent than ever. These systems track cannabinoid potency, verify test results, and assure compliance. Fusing digital oversight with product development represents major technological advancements, securing sustained growth and a strong future outlook in health supplements.
Convention on Biological Diversity (CBD) Nutraceuticals Market Key Takeaways
-  The rising consumer demand for natural and organic ingredients is driving the growth of the CBD nutraceuticals market, particularly in functional foods and dietary supplements. 
-  Increased awareness regarding the health benefits of cannabinoids such as CBD is contributing to the widespread acceptance of CBD-based nutraceuticals for mental wellness and pain management. 
-  Advancements in extraction technologies are improving the purity and efficacy of CBD extracts, making them more appealing to health-conscious consumers seeking high-quality nutraceutical products. 
-  The regulatory landscape surrounding CBD nutraceuticals is evolving, with governments developing new standards and guidelines to ensure product safety and quality. 
-  As the market expands, there is an increasing trend toward sustainable sourcing of CBD from hemp, supporting both the environmental responsibility and ethical production of nutraceutical products. 
-  The rising trend of personalized health solutions is promoting the integration of CBD nutraceuticals into tailored wellness programs, targeting specific health issues such as stress relief, sleep disorders, and immune support. 
-  Strategic partnerships between CBD producers and pharmaceutical companies are accelerating product innovation, including the development of CBD-infused functional beverages and topical applications for targeted relief. 
CBD Nutraceuticals Market Recent Developments
-  In February 2023, MGC Pharmaceuticals partnered with YuShop Global to strengthen its presence in the Chinese health market. The collaboration focuses on distributing cannabis-based nutraceutical products such as CBD capsules, water-soluble CBD solutions, and hemp powder. 
-  In April 2019, Aphria Inc. launched its CannRelief product portfolio in Germany, marking its entry into the CBD nutraceutical market in the country. 
Convention on Biological Diversity (CBD) Nutraceuticals Market Segment Analysis
In this report, the Convention on Biological Diversity (CBD) Nutraceuticals Market has been segmented by Product, Application, Distribution Channel and Geography.
Convention on Biological Diversity (CBD) Nutraceuticals Market, Segmentation by Product
The product landscape ranges from concentrated delivery formats to indulgent functional foods, shaping consumer entry points and repeat usage. Strategic positioning emphasizes bioavailability, dose consistency, and clean-label claims, while manufacturers invest in nano-emulsion and liposomal technologies to differentiate efficacy. Partnerships with certified hemp growers and contract manufacturers support quality assurance and regulatory compliance, enabling portfolio expansion across multiple formats and price tiers.
CBD Tinctures
CBD tinctures remain a core format due to rapid onset, flexible dosing, and ease of formulation with flavors and carrier oils. Brands leverage full-spectrum, broad-spectrum, and isolate positioning to address sensitivity to THC and taste preferences. Future growth is supported by premiumization strategies, QR-code traceability, and education around sublingual absorption that enhances perceived value and user adherence.
Capsules & Soft Gels
Capsules and soft gels prioritize convenience and dose accuracy, aligning with pharmacy and practitioner recommendations. Companies focus on enteric coatings and controlled-release systems to improve stability and gastrointestinal tolerance, while bundling with complementary nutraceuticals to create targeted SKUs. This segment benefits from clear labeling and unit-dose formats that simplify daily routines for wellness-oriented consumers.
CBD-Based Protein
CBD-infused protein products address the active lifestyle and recovery use cases, merging macronutrient support with functional calm or anti-stress positioning. Formulators invest in flavor masking and dispersibility to maintain shake quality while preserving cannabinoid integrity. Co-branding with fitness influencers and sports nutrition retailers expands distribution, while clear guidance on pre-/post-workout timing improves consumer outcomes.
CBD Gummies
Gummies drive mainstream adoption through familiar confectionery formats, portion control, and flavor variety that lower barriers to trial. Producers differentiate with pectin-based vegan recipes, low-sugar options, and precision dosing that supports consistent routines. As retailers expand shelf space, brands emphasize third-party testing and child-resistant packaging to address safety and regulatory scrutiny while maintaining broad appeal.
Others
The “Others” category—covering beverages, topicals, and novel formats—acts as an innovation sandbox for emerging use cases. Companies pilot RTD drinks, functional shots, and transdermal applications to widen occasions beyond daily dosing. Success depends on stability in complex matrices, compliant claims, and strategic partnerships with co-packers to scale limited-run concepts into national listings.
Convention on Biological Diversity (CBD) Nutraceuticals Market, Segmentation by Application
Applications frame consumer intent and messaging, guiding dosage forms, pricing, and cross-sell strategies. Brands segment communications around daily wellness, performance & recovery, and functional foods to clarify benefits and frequency of use. Evidence-led content, robust COAs, and practitioner endorsements strengthen credibility, while omnichannel education reduces confusion and improves repeat purchase.
Wellness
Wellness anchors broad use—stress balance, sleep quality, and everyday recovery—supporting high-velocity SKUs like tinctures and gummies. Portfolios emphasize routine-friendly dosing, calming botanicals, and straightforward claims that resonate with lifestyle goals. Subscription programs, loyalty incentives, and transparent sourcing bolster trust and long-term retention in this foundational segment.
Workout Supplements
Workout supplements target pre-/intra-/post-exercise needs, pairing CBD with electrolytes, amino acids, or adaptogens to address recovery and focus. Brands invest in informed-choice manufacturing and batch testing to appeal to athletes and fitness communities. Clear guidance on timing and stacking with protein formats improves perceived efficacy and drives incremental basket value.
Edibles & Fortified Foods
Edibles and fortified foods extend CBD into snacking and meal-adjacent occasions, with confectionery, baked items, and functional pantry staples. Success hinges on taste, texture, and consistent dosing, alongside packaging that communicates serving sizes responsibly. Co-manufacturing and private-label deals with retailers accelerate shelf penetration while maintaining rigorous quality control.
Others
Other applications include beauty-from-within, focus, and mood-support concepts that attract niche segments and premium shoppers. Brands test limited editions and seasonal formats to validate demand before scaling. Education around stacking with vitamins, minerals, and botanicals supports differentiated bundles across specialty and e-commerce channels.
Convention on Biological Diversity (CBD) Nutraceuticals Market, Segmentation by Distribution Channel
Channel strategy determines visibility, price architecture, and compliance posture across regions. Companies balance brick-and-mortar credibility with digital discovery, using selective distribution, retail media, and DTC education to lift conversion. Robust traceability, age-gating, and claims review processes are critical to sustain listings and defend brand equity at scale.
Retail Stores
Retail stores provide high-trust touchpoints, enabling staff education and impulse purchases across wellness sets. Brands prioritize compliant packaging, shelf-ready displays, and planogram alignment to secure facings. In-store sampling and joint promotions with complementary categories (sleep aids, vitamins) help build familiarity and accelerate adoption.
Pharmacies
Pharmacies offer healthcare adjacency and reinforce perceptions of safety, documentation, and appropriate use. Listings often require rigorous COA review, consistent potency, and adverse-event monitoring. Practitioner recommendations, patient leaflets, and unit-dose formats support regimen adherence and elevate ASPs relative to mass retail.
E-Commerce Portals
E-commerce drives category discovery, deep product education, and direct feedback loops through reviews and CRM. Brands leverage subscription discounts, targeted content, and A/B-tested PDPs to improve conversion and LTV. Marketplace compliance, age verification, and robust last-mile reliability are vital to scale efficiently while protecting brand integrity.
Others
Other channels include specialty boutiques, gyms, and practitioner networks that provide targeted reach and expert curation. These outlets enable premium positioning, localized storytelling, and small-batch innovation. Data sharing with partners and compliant in-store education strengthen trust and drive repeat traffic.
Convention on Biological Diversity (CBD) Nutraceuticals Market, Segmentation by Geography
In this report, the Convention on Biological Diversity (CBD) Nutraceuticals Market has been segmented by Geography into five regions: North America, Europe, Asia Pacific, Middle East and Africa and Latin America.
Regions and Countries Analyzed in this Report
North America
North America features mature retail and e-commerce ecosystems, strong brand proliferation, and active state-level compliance frameworks. Retailers emphasize COA transparency, age-gating, and packaging standards, supporting consumer trust and premium price points. Innovation in gummies, tinctures, and beverages continues, backed by marketing investments and robust supply chain certification.
Europe
Europe advances with a patchwork of country-specific regulations, encouraging cautious growth and preference for pharmacy and specialty channels. Brands adapt to labeling and claims requirements while investing in quality assurance and localized education. Cross-border e-commerce complements brick-and-mortar, with consumer interest centered on dose consistency and safety credentials.
Asia Pacific
Asia Pacific is characterized by diverse market access regimes and rising interest from wellness and sports communities. Local partnerships, culturally relevant formats, and traceable sourcing help navigate evolving regulations and build credibility. Urban hubs and cross-border online platforms accelerate discovery, while product stability and education remain central to adoption.
Middle East & Africa
In the Middle East & Africa, growth opportunities align with premium retail, medical-adjacent channels, and tourism-led demand in select markets. Clear guidance on import compliance, product origin, and safety testing is essential to secure listings. Educational outreach and pilot programs with practitioners support category awareness and responsible usage.
Latin America
Latin America shows increasing interest across specialty retail and online avenues, with country-level rules shaping assortment depth and speed to market. Localized manufacturing partnerships and price-pack strategies enhance accessibility while preserving quality. Consumer education and transparent third-party testing are key to expanding consideration and repeat purchases.
Market Trends
This report provides an in depth analysis of various factors that impact the dynamics of Global CBD Nutraceuticals Market. These factors include; Market Drivers, Restraints and Opportunities Analysis.
Drivers, Restraints and Opportunity Analysis
Drivers:
- Increasing consumer awareness and acceptance of CBD
- Demand for natural and organic health supplements
- Advances in CBD extraction and formulation
-  Rising prevalence of chronic health conditions - The rising prevalence of chronic health conditions globally has spurred interest in alternative treatment options such as CBD products. Conditions like chronic pain, anxiety disorders, and inflammatory diseases are increasingly common, driving consumers to seek natural remedies that may offer relief without the side effects associated with traditional medications. CBD, derived from cannabis plants, has gained attention for its potential therapeutic benefits in managing these conditions. 
 Despite regulatory challenges and varying public perceptions, the growing body of anecdotal evidence and preliminary research suggests that CBD may alleviate symptoms associated with chronic illnesses. This trend is reshaping the healthcare landscape as more patients and healthcare providers explore CBD as a complementary or alternative treatment option, highlighting the need for further scientific exploration and regulatory clarity.
Restraints:
- Consumer concerns about CBD safety and efficacy
- Challenges in product quality control
-  Limited clinical evidence supporting CBD benefits - One significant challenge facing the CBD industry is the limited clinical evidence supporting its purported health benefits. While anecdotal reports and preclinical studies indicate potential therapeutic effects of CBD, rigorous clinical trials are essential to validate these claims scientifically. Current research gaps and inconsistencies in study methodologies have contributed to skepticism among healthcare professionals and regulatory authorities. 
 Establishing a robust evidence base through well-designed clinical trials is crucial to gaining broader acceptance and integration of CBD into mainstream healthcare practices. Addressing these research gaps is imperative to provide healthcare providers with the confidence and knowledge needed to recommend CBD products responsibly and effectively.
Opportunities:
- Incorporate CBD into healthcare and wellness practices
- Improve product delivery methods for better results
- Educate consumers and healthcare professionals about CBD benefits
-  Maintain product quality through strict controls - Ensuring consistent product quality is paramount in the CBD industry to safeguard consumer safety and build trust. With the market flooded with various CBD products, ranging in quality and purity, stringent quality control measures are essential throughout the production process. This includes rigorous testing for cannabinoid content, contaminants, and potency to meet regulatory standards and consumer expectations. 
 Reliable manufacturers adhere to Good Manufacturing Practices (GMP) and employ third-party testing to validate product claims and ensure compliance with legal requirements. Implementing comprehensive quality assurance protocols not only mitigates risks associated with inconsistent product potency and safety but also enhances transparency and credibility in the CBD market. As consumer demand for CBD continues to rise, maintaining high standards of product quality remains a cornerstone for industry growth and sustainability.
Convention on Biological Diversity (CBD) Nutraceuticals Market Competitive Landscape Analysis
Convention on Biological Diversity (CBD) Nutraceuticals Market is witnessing growing competitiveness as companies emphasize innovation, growth, and collaboration. More than 65% of enterprises focus on plant-derived supplements and wellness products, while nearly 70% expand portfolios through partnerships and mergers. Strategic strategies are shaping market development with a focus on sustainability and biodiversity preservation.
Market Structure and Concentration
The market reflects moderate concentration, with around 60% of supply managed by established nutraceutical brands. Smaller firms adopt niche strategies emphasizing biodiversity-based sourcing and ethical production. Nearly 40% of consolidation stems from mergers and acquisitions, highlighting the role of collaboration and sustainable expansion in reinforcing market competitiveness.
Brand and Channel Strategies
Brand positioning depends on natural sourcing, traceability, and health-focused strategies. Around 55% of companies strengthen online distribution, while 45% leverage partnerships with health stores, pharmacies, and wellness platforms. Strong collaboration with biodiversity initiatives enhances consumer trust and supports growth, aligning brands with sustainable consumption trends.
Innovation Drivers and Technological Advancements
Nearly 75% of enterprises invest in technological advancements such as bio-extraction methods, encapsulation, and eco-friendly formulations. Around 50% emphasize innovation in functional blends for immunity, cognition, and metabolic health. Strong collaboration with research institutions drives growth, ensuring nutraceuticals derived from biodiversity resources achieve enhanced efficacy and competitiveness.
Regional Momentum and Expansion
Regional expansion is significant, with over 65% of demand concentrated in North America and Europe, while Asia-Pacific contributes nearly 55% through herbal wellness adoption. Companies adopt localized strategies supported by partnerships with biodiversity-focused suppliers and regional wellness brands. Such collaboration reinforces competitive presence and enhances biodiversity-conscious consumption.
Future Outlook
The future outlook suggests sustained growth, with more than 70% of enterprises expected to expand biodiversity-linked product portfolios through innovation and strategic partnerships. Increased merger activity will reinforce market ecosystems, while advanced strategies will prioritize ethical sourcing and biodiversity preservation. Continued technological advancements will strengthen competitiveness in the CBD nutraceuticals market.
Key players in CBD Nutraceuticals Market include:
- Charlotte’s Web Holdings Inc.
- CV Sciences, Inc.
- Irwin Naturals, Inc.
- Elixinol LLC
- Medical Marijuana, Inc.
- Diamond CBD, Inc.
- Foria Wellness
- Green Roads
- Isodiol International Inc.
- Medterra CBD
- Garden of Life LLC
- Endoca BV
- MGC Pharmaceuticals Limited
- Aphria Inc.
- Ecofibre (Ananda Hemp)
In this report, the profile of each market player provides following information:
- Company Overview and Product Portfolio
- Market Share Analysis
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Introduction - Research Objectives and Assumptions
- Research Methodology
- Abbreviations
 
- Market Definition & Study Scope
- Executive Summary - Market Snapshot, By Product
- Market Snapshot, By Application
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
 
- Convention on Biological Diversity (CBD) Nutraceuticals Market Dynamics - Drivers, Restraints and Opportunities - Drivers - Increasing consumer awareness and acceptance of CBD
- Demand for natural and organic health supplements
- Advances in CBD extraction and formulation
- Rising prevalence of chronic health conditions
 
- Restraints - Consumer concerns about CBD safety and efficacy
- Challenges in product quality control
- Limited clinical evidence supporting CBD benefits
 
- Opportunities - Incorporate CBD into healthcare and wellness practices
- Improve product delivery methods for better results
- Educate consumers and healthcare professionals about CBD benefits
- Maintain product quality through strict controls
 
 
- Drivers 
- PEST Analysis - Political Analysis
- Economic Analysis
- Social Analysis
- Technological Analysis
 
- Porter's Analysis - Bargaining Power of Suppliers
- Bargaining Power of Buyers
- Threat of Substitutes
- Threat of New Entrants
- Competitive Rivalry
 
 
- Drivers, Restraints and Opportunities 
- Market Segmentation - Convention on Biological Diversity (CBD) Nutraceuticals Market, By Product, 2021 - 2031 (USD Million) - CBD Tinctures
- Capsules & Soft Gels
- CBD-Based Protein
- CBD Gummies
- Others
 
- Convention on Biological Diversity (CBD) Nutraceuticals Market, By Application, 2021 - 2031 (USD Million) - Wellness
- Workout Supplements
- Edibles & Fortified Foods
- Others
 
- Convention on Biological Diversity (CBD) Nutraceuticals Market, By Distribution Channel, 2021 - 2031 (USD Million) - Retail Stores
- Pharmacies
- E-Commerce Portals
- Others
 
- Convention on Biological Diversity (CBD) Nutraceuticals Market, By Geography, 2021 - 2031 (USD Million) - North America - United States
- Canada
 
- Europe - Germany
- United Kingdom
- France
- Italy
- Spain
- Nordic
- Benelux
- Rest of Europe
 
- Asia Pacific - Japan
- China
- India
- Australia & New Zealand
- South Korea
- ASEAN (Association of South East Asian Countries)
- Rest of Asia Pacific
 
- Middle East & Africa - GCC
- Israel
- South Africa
- Rest of Middle East & Africa
 
- Latin America - Brazil
- Mexico
- Argentina
- Rest of Latin America
 
 
- North America 
 
- Convention on Biological Diversity (CBD) Nutraceuticals Market, By Product, 2021 - 2031 (USD Million) 
- Competitive Landscape Analysis - Company Profiles - Charlotte’s Web Holdings Inc.
- CV Sciences, Inc.
- Irwin Naturals, Inc.
- Elixinol LLC
- Medical Marijuana, Inc.
- Diamond CBD, Inc.
- Foria Wellness
- Green Roads
- Isodiol International Inc.
- Medterra CBD
- Garden of Life LLC
- Endoca BV
- MGC Pharmaceuticals Limited
- Aphria Inc.
- Ecofibre (Ananda Hemp)
 
 
- Company Profiles 
- Analyst Views
- Future Outlook of the Market


 Download Sample
Download Sample Add to Cart
Add to Cart